This site is intended for healthcare professionals only

In association with the Cardiorenal Forum

Articles

  • Alternative complement pathway inhibition with iptacopan in IgA nephropathy

  • Iptacopan in IgA nephropathy

  • PARAGON-HF: Kidney function and cardiovascular outcomes with sacubitril/valsartan

  • Rack of blood sample tubes

    Do we fully understand the risk factors associated with venous thromboembolism in nephrotic syndrome?

  • Risk of thromboembolic events in patients with nephrotic syndrome and relatively high albumin levels

  • Effects of heart failure therapies on standardised kidney outcomes

  • Use and safety of finerenone in a routine setting: first interim results from FINE-REAL

  • Sick man in hospital bed

    Unravelling the sex differences and decline in kidney health after 73 years of age

  • Sex, cardiometabolic risk factors and eGFR decline

alt

For the latest news and articles
Sign up to Renal Review newsletters

Subscribe